Related Experiment Video

Updated: May 6, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.9K

Viral-bacterial interactions-therapeutic implications

Jane C Deng1

  • 1Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Influenza and Other Respiratory Viruses
|November 13, 2013
PubMed

Insights

Viral and bacterial respiratory infections increase disease severity. This review examines co-infection impacts, mechanisms, and management strategies for better patient outcomes.

Area of Science:

  • Respiratory infections
  • Infectious diseases
  • Microbiology

Background:

  • Viral and bacterial respiratory infections cause significant global morbidity and mortality.
  • Co-infections often lead to more severe illness than single infections.
  • Bacterial superinfections, particularly after influenza, are a major cause of death during pandemics.

Purpose of the Study:

  • To review the epidemiology and global impact of viral and bacterial respiratory co-infections.
  • To explore the mechanisms by which viral infections facilitate bacterial co-infections.
  • To discuss current diagnostic and treatment strategies for these co-infections.

Main Methods:

  • Literature review and analysis of epidemiological data.
  • Examination of mechanistic studies on host-pathogen interactions.
  • Synthesis of current clinical management guidelines.

Main Results:

  • Co-infections significantly increase disease severity and mortality.
  • Viral infections can enhance bacterial adherence, colonization, and virulence.
  • Effective diagnosis and treatment of co-infections remain challenging.

Conclusions:

  • Understanding viral-bacterial interactions is crucial for developing novel therapies.
  • Improved diagnostic tools and treatment protocols are needed.
  • Further research into co-infection mechanisms can mitigate severe respiratory illness.
Keywords:
bacterial pneumoniainfluenzapolymicrobial infectionsrespiratory viral infection

More Related Videos

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.2K
Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice08:46

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice

Published on: January 26, 2024

2.8K

Related Concept Videos

Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
732
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.4K
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
54
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
60.5K